The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...

OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

Advancement in Nanoparticle-Based NIRF Probes for Precision Visualization in Oncology. Open Access Library Journal, 12, 1-14. doi: 10.4236/oalib.1112471 . Molecular imaging has introduced new ...

Increases speed to market for drug developers working on nucleic acid therapeutics.

Spray Pyrolysis Market Spray Pyrolysis Market Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Spray Pyrolysis Market by Device ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

The Gulf’s rulers want to do better than that. Beset with the rising urgency to diversify their economies away from fossil ...

Vertex aims to further bolster its gene-editing therapy pipeline by using Orna's lipid nanoparticle delivery technologies during the three-year collaboration.

Introducing a bioresorbable acoustic microrobot that navigates complex biofluids, ensuring targeted therapy with real-time ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five years ...